Patricia Eckert
Director of Finance/CFO chez ENZO BIOCHEM, INC.
Fortune : 24 638 $ au 31/03/2024
Profil
Patricia Eckert is currently the Chief Financial Officer at Enzo Biochem, Inc. She previously worked as the Accounting Director at Pall Corp.
from 2013 to 2017.
Ms. Eckert completed her undergraduate degree and MBA at Hofstra University.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
ENZO BIOCHEM, INC.
0,04% | 23/02/2024 | 19 400 ( 0,04% ) | 24 638 $ | 31/03/2024 |
Postes actifs de Patricia Eckert
| Sociétés | Poste | Début |
|---|---|---|
| ENZO BIOCHEM, INC. | Director of Finance/CFO | - |
Anciens postes connus de Patricia Eckert
| Sociétés | Poste | Fin |
|---|---|---|
| PALL CORPORATION | Comptroller/Controller/Auditor | 01/08/2017 |
Formation de Patricia Eckert
| Hofstra University | Masters Business Admin |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| ENZO BIOCHEM, INC. | Health Technology |
| Entreprise privées | 1 |
|---|---|
Pall Corp.
 Pall Corp. Medical SpecialtiesHealth Technology Pall Corp. designs, manufactures, and markets filtration and separation equipment. Its products are used to remove solid, liquid, and gaseous contaminants from a variety of liquids and gases. The firm has Life Sciences and Industrial segments. The Life Sciences segment focuses on developing, manufacturing, and selling products to customers in the medical, biopharmaceuticals, and food and beverage markets. The Industrial segment focuses on developing, manufacturing and selling products to customers in the process technologies, aerospace, and microelectronics markets. The company was founded by David B. Pall on July 31, 1946 and is headquartered in Port Washington, NY. | Health Technology |
